Trials / Unknown
UnknownNCT05313061
MTX Hold During Covid-19 Booster
Effect of One-week Discontinuation of Methotrexate on Immunogenicity of COVID-19 Booster Vaccination in Patients With Rheumatoid Arthritis: A Randomized Pilot Study
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the effect of MTX discontinuation for 1 week on vaccination response to Covid-19 booster vaccination in RA patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MTX | MTX continuation |
Timeline
- Start date
- 2021-12-29
- Primary completion
- 2022-12-30
- Completion
- 2022-12-30
- First posted
- 2022-04-06
- Last updated
- 2022-04-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05313061. Inclusion in this directory is not an endorsement.